They aren't just "pandemic stocks." ...

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could drive $36–42 upside—read now.

Uğur Şahin and Özlem Türeci, a Turkish husband-and-wife team, became unlikely celebrities during the pandemic for their world ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

ALBANY, NY (News10) – Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...

U.S. mRNA Therapeutics Market is estimated at USD 6.85 billion in 2025 and is expected to reach USD 33.04 billion by 2035 owing to the extensive biotechnology infrastructure in the countryAustin, ...

BioNTech's co-founders Ugur Sahin and Oezlem Tuereci plan to leave the company by 2026 to establish a new venture focused on mRNA technology. While ensuring BioNTech's existing operations continue ...

The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Comirnaty (Tozinameran) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

Ugur Sahin and Özlem Türeci, who directed the COVID vaccine maker’s rise to prominence, will helm an as-yet-unnamed company ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...